Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response

125Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Synthetic scaffolds are crucial to applications in regenerative medicine; however, the foreign body response can impede regeneration and may lead to failure of the implant. Herein we report the development of a tissue engineering scaffold that allows attachment and proliferation of regenerating cells while reducing the foreign body response by localized delivery of an anti-inflammatory agent. Electrospun fibers composed of poly(l-lactic) acid (PLLA) and poly(ε-caprolactone) (PCL) were prepared with and without the steroid anti-inflammatory drug, dexamethasone. Analysis of subcutaneous implants demonstrated that the PLLA fibers encapsulating dexamethasone evoked a less severe inflammatory response than the other fibers examined. They also displayed a controlled release of dexamethasone over a period of time conducive to tissue regeneration and allowed human mesenchymal stem cells to adhere to and proliferate on them in vitro. These observations demonstrate their potential as a building block for tissue engineering scaffolds. © 2012 American Chemical Society.

Cite

CITATION STYLE

APA

Vacanti, N. M., Cheng, H., Hill, P. S., Guerreiro, J. D. T., Dang, T. T., Ma, M., … Anderson, D. G. (2012). Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response. Biomacromolecules, 13(10), 3031–3038. https://doi.org/10.1021/bm300520u

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free